SCHEMBL23959209

SCHEMBL23959209

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1ccc(-c2cnc3nc(-c4ccccc4)c(-c4ccccc4)n3c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 8/20 0.51
▸ AKT2 P31751 8/20 0.51
▸ KDM4E B2RXH2 3/20 0.38
▸ DHODH Q02127 1/20 0.38
▸ ROCK2 O75116 1/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ CYP2C9 P11712 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959491 0.91 AKT1 (0.54) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959240 0.89 AKT1 (0.53) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959101 0.89 AKT1 (0.47) AKT1AKT2KDM4EDHODHROCK2
SCHEMBL23959492 0.88 AKT1 (0.52) AKT1AKT2KDM4EROCK2PIM1
SCHEMBL23959215 0.88 AKT1 (0.49) AKT1AKT2DHODHROCK2PIM1
SCHEMBL23959244 0.88 AKT1 (0.51) AKT1AKT2KDM4EROCK2PIM1
SCHEMBL23959210 0.87 AKT1 (0.46) AKT1AKT2KDM4EDHODHROCK2
SCHEMBL23959207 0.87 AKT1 (0.56) AKT1AKT2KDM4EROCK2PIM1
SCHEMBL23959214 0.87 AKT1 (0.45) AKT1AKT2KDM4EDHODHROCK2
SCHEMBL23959493 0.86 AKT1 (0.48) AKT1AKT2DHODHROCK2PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-12-07 — — US disclosed
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885KDM4E 2663/4885
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885KDM4E 2663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback